KELLI LEEK: Open Payments
NPI 1780029603 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,731 in 76 payments from 28 companies in 2025. Trend: 2023 $1,260 · 2024 $3,446 · 2025 $1,731
Food & beverage: $1,731
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 4 | $284 |
| Eisai Inc. | 7 | $215 |
| Teva Pharmaceuticals USA, Inc. | 9 | $210 |
| PFIZER INC. | 13 | $176 |
| Lundbeck LLC | 6 | $110 |
| UCB, Inc. | 4 | $90 |
| SK Life Science, Inc. | 4 | $74 |
| Neurocrine BioSciences, Inc. | 3 | $68 |
| TG Therapeutics, Inc. | 3 | $65 |
| Lilly USA, LLC | 4 | $56 |
Products named: VNS THERAPY SENTIVA MODEL 1000 GENERATOR, Leqembi, AUSTEDO XR, NURTEC ODT, VYEPTI, INGREZZA, Briviact, BRIUMVI.
Industry payments across OK — which companies pay providers there.
